Google Chrome
Safari
Firefox
Edge
Article / Nov 01, 2020
A novel amorphous solid dispersion based on drug-polymer complexation
Drug delivery and translational research (2020)
Search
Press Clipping / Jan 24, 2022
Hovione will expand 3 pharmaceutical chemistry facilities
C&EN, 21 November 2021
Dispersome®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Press Clipping / Feb 17, 2022
Seven Companies in Ireland achieve the Business Working Responsibly mark with a further ten recertifying to the standard
BITCI Ireland, 17 February 2022
Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
Press Clipping / Jan 17, 2022
Pharmaceutical services to grow for another year
C&EN, 17 January 2022
Press Release / Feb 22, 2022
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
TwinCaps® DPI
World’s largest selling disposable DPI.